MicroSecure Vitrification (μS-VTF) Procedure


MicroSecure Vitrification (μS-VTF) Procedure: Optimum simplicity, security, cost-savings and effectiveness combining FDA-approved products

A pioneering scientific breakthrough in embryo cryopreservation called “vitrification” (VTF) occurred in a series of experiments conducted in a cold room at the American Red Cross in Bethesda, MD in the mid-1980’s (Fahy et al., 1984; Rall & Fahy, 1985; Fahy, 1986). Using highly concentrated solutes and cryoprotective agents, a “metastable glass phase” could be achieved without ice crystal formation (i.e., vitrification) under rapid cooling conditions (>100°C/ min) in LN2. The third generation of vitrification solutions (VS3a), a 6.5M glycerol-based VS, developed by William Rall was effectively applied to mouse and…
[/three_fourths] [one_fourth_last][/one_fourth_last]

[issuu width=930 height=700 pageNumber=33 shareMenuEnabled=false printButtonEnabled=false backgroundColor=%23222222 documentId=120221235537-f7a39ec9b7c647b8b6d5bab5121ef1ae name=jce-13-2 username=embryologists.com tag=clinical unit=px id=c9ab17c4-7cad-e195-029c-14569eb4bddf v=2]

Leave a comment